United States · FDA National Drug Code directory
TICAGRELOR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-368_fb424a50-a319-4227-851f-2f59d236adf2
- Product NDC
- 72205-368
- Form
- TABLET
- Composition / generic term
- TICAGRELOR
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200407
- Source listing expiry
- 20271231
Source-listed ingredients
- TICAGRELOR — 90 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 BOX, UNIT-DOSE (72205-368-11) / 10 TABLET in 1 BLISTER PACK · 72205-368-11
- 180 TABLET in 1 BOTTLE (72205-368-18) · 72205-368-18
- 60 TABLET in 1 BOTTLE (72205-368-60) · 72205-368-60
- 100 TABLET in 1 BOTTLE (72205-368-91) · 72205-368-91
- 1000 TABLET in 1 BOTTLE (72205-368-99) · 72205-368-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →